Literature DB >> 19354233

A convergent synthesis of the proposed structure of antitumor depsipeptide stereocalpin A.

Arun K Ghosh1, Chun-Xiao Xu.   

Abstract

The total synthesis of the proposed structure of anticancer agent stereocalpin A is described. The synthesis features a diastereoselective synthesis of a 5-hydroxy-2,4-dimethyl-3-oxooctanoic acid unit with asymmetric anti- and syn-aldol reactions as the key steps. Initial cycloamidation led to complete epimerization at the C-11 stereocenter due to unique steric constraints in the 12-membered depsipeptide ring. A late-stage methylation strategy led to the synthesis of the proposed structure of stereocalpin A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19354233      PMCID: PMC3179852          DOI: 10.1021/ol900412u

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  9 in total

1.  Enantioselective Synthesis of the Elaiophylin Aglycon.

Authors:  David A. Evans; Duke M. Fitch
Journal:  J Org Chem       Date:  1997-02-07       Impact factor: 4.354

2.  Solution-phase parallel synthesis of a pharmacophore library of HUN-7293 analogues: a general chemical mutagenesis approach to defining structure-function properties of naturally occurring cyclic (depsi)peptides.

Authors:  Yan Chen; Melitta Bilban; Carolyn A Foster; Dale L Boger
Journal:  J Am Chem Soc       Date:  2002-05-15       Impact factor: 15.419

3.  Assignment of absolute stereochemistry and total synthesis of (-)-spongidepsin.

Authors:  Arun K Ghosh; Xiaoming Xu
Journal:  Org Lett       Date:  2004-06-10       Impact factor: 6.005

4.  Cyclization of all-L-Pentapeptides by Means of 1-Hydroxy-7-azabenzotriazole-Derived Uronium and Phosphonium Reagents.

Authors:  Angelika Ehrlich; Hans-Ulrich Heyne; Rüdiger Winter; Michael Beyermann; Hanka Haber; Louis A. Carpino; Michael Bienert
Journal:  J Org Chem       Date:  1996-12-13       Impact factor: 4.354

5.  Total synthesis of antitumor depsipeptide (-)-doliculide.

Authors:  A K Ghosh; C Liu
Journal:  Org Lett       Date:  2001-02-22       Impact factor: 6.005

6.  Enantioselective total synthesis of (+)-amphidinolide t1.

Authors:  Arun K Ghosh; Chunfeng Liu
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

7.  Enantioselective total synthesis of (+)-largazole, a potent inhibitor of histone deacetylase.

Authors:  Arun K Ghosh; Sarang Kulkarni
Journal:  Org Lett       Date:  2008-07-29       Impact factor: 6.005

8.  Enantioselective total synthesis of +-jasplakinolide.

Authors:  Arun K Ghosh; Deuk Kyu Moon
Journal:  Org Lett       Date:  2007-05-08       Impact factor: 6.005

9.  (-)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly.

Authors:  Ruoli Bai; David G Covell; Chunfeng Liu; Arun K Ghosh; Ernest Hamel
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

  9 in total
  5 in total

1.  Synthesis of Bioactive Natural Products by Asymmetric syn- and anti-Aldol Reactions.

Authors:  Arun K Ghosh; Zachary L Dawson
Journal:  Synthesis (Stuttg)       Date:  2009-09       Impact factor: 3.157

2.  Capturing the essence of organic synthesis: from bioactive natural products to designed molecules in today's medicine.

Authors:  Arun K Ghosh
Journal:  J Org Chem       Date:  2010-10-11       Impact factor: 4.354

Review 3.  Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades.

Authors:  Cheng-Shi Jiang; Lin-fu Liang; Yue-wei Guo
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

Review 4.  Cyclic Peptides for the Treatment of Cancers: A Review.

Authors:  Dalifa Ramadhani; Rani Maharani; Amirah Mohd Gazzali; Muchtaridi Muchtaridi
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

5.  The taumycin A macrocycle: asymmetric total synthesis and revision of relative stereochemistry.

Authors:  Justine N deGruyter; William A Maio
Journal:  Org Lett       Date:  2014-09-23       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.